Tropisetron ameliorates ischemic brain injury in an embolic model of stroke

Brain Research

Volumn 1392, Issue , 2011, Pages 101-109

  Rahimian, Reza ^a   Daneshmand, Ali ^b,c   Mehr, Shahram Ejtemaei ^a   Barzegar Fallah, Anita ^d   Mohammadi Rick, Sanaz ^a   Fakhfouri, Gohar ^e   Shabanzadeh, Alireza P ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Embolic stroke; Infarct volume; Tropisetron

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; GRANISETRON; MYELOPEROXIDASE; TACROLIMUS; TROPISETRON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; BRAIN EMBOLISM; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOEMBOLISM;

ANALYSIS OF VARIANCE; ANIMALS; BIGUANIDES; BLOOD GAS ANALYSIS; BRAIN EDEMA; BRAIN INFARCTION; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; INDOLES; ISCHEMIA; MALE; NERVOUS SYSTEM DISEASES; PEROXIDASE; RATS; RATS, WISTAR; SEIZURES; SEROTONIN ANTAGONISTS; STROKE; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 79955934430     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.03.053     Document Type: Article

References (25)

1. Allahtavakoli, M., Moloudi, R., Arababadi, M.K., Shamsizadeh, A., Javanmardi, K., 2009. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat. Brain Res. 1271, 121-127.
2. Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimora, M.C., Davis, R.L., 1986. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke 17, 472-476. (Pubitemid 16085691)
3. Candelario-Jalil, E., Muñoz, E., Fiebich, B.L., 2008. Detrimental effects of tropisetron on permanent ischemic stroke in the rat. BMC Neurosci. 9, 19.
4. De Rosa, M.J., Dionisio, L., Agriello, E., Bouzat, C., del Carmen Esandi, M., 2009. Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci. 85, 444-449.
5. Dijkhuizen, R.M., Asahi, M., Wu, O., Rosen, B.R., Lo, H., 2001. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J. Cereb. Blood. F. Met. 21, 964-971.
6. Dirnagl, U., Iadecola, C., Moskowitz, M.A., 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397. (Pubitemid 29453643)
7. Faerber, L., Drechsler, S., Ladenburger, S., Gschaidmeier, H., Fischer, W., 2007. The neuronal 5-HT3 receptor network after 20 years of research-evolving concepts in management of pain and inflammation. Euro. J. Pharmacol. 560, 1-8.
8. Fakhfouri, G., Rahimian, R., Daneshmand, A., Bahremand, A., Rasouli, M.R., Dehpour, A.R., 2010. Granisetron ameliorates acetic acid-induced colitis in rats. Hum. Exp. Toxicol. 29 (4), 321-328.
9. Fiebich, B.L., Akundi, R.S., Lieb, K., Candelario-Jalil, E., Gmeiner, D., Haus, U., et al., 2004. Anti-inflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes. Scand. J. Rheumatol. 33, 28-32.
10. Haddad, M., Rhinn, H., Bloquel, C., Coqueran, B., Szabó, C., Plotkine, M., et al., 2006. Anti-inflammatory effects of PJ34, a poly (ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br. J. Pharmacol. 149, 23-30.
11. Kaminska, B., Gaweda-Walerych, K., Zawadzka, M., 2004. Molecular mechanisms of neuroprotective action of immunosuppressants - facts and hypotheses. J. Cell. Mol. Med. 8 (1), 45-58.
12. Kapadia, R., Yi, J.H., Vemuganti, R., 2008. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front. Biosci. 13, 1813-1826.
13. Lucas, S.M., Rothwell, N.J., Gibson, R.M., 2006. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147, S232-S240.
14. 3 receptor antagonist granisetron on inflammatory parameters and angiogenesis in the air-pouch model of inflammation. Int. Immunopharmacol. 10 (9), 1010-1016.
15. Morioka, M., Fukunaga, K., Hasegawa, S., Okamura, A., Korematsu, K., Kai, Y., et al., 1999. Activities of calcineurin and phosphatase 2A in the hippocampus after transient forebrain ischemia. Brain Res. 828, 135-144. (Pubitemid 29236483)
16. Mössner, R., Lesch, K.P., 1998. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12 (4), 249-271.
17. 3 receptor antagonist, tropisetron on experimental colitis in rats. Eur. J. Clin. Invest. 39, 375-383.
18. 3 receptor antagonists in rheumatic diseases. Curr. Top. Med. Chem. 6, 2035-2042.
19. Muramoto, M., Yamazaki, T., Nishimura, S., Kita, Y., 2003. Detailed in vitro pharmacological analysis of FK506-induced neuroprotection. Neuropharmacology 45, 394-403. (Pubitemid 36836135)
20. Shabanzadeh, A.R., Shuaib, A., Wang, C.X., 2005. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res. 1042, 1-5.
21. Shuaib, A., Wang, C.X., Yang, T., Noor, R., 2002. Effects of nonpeptide V1 vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke 33, 3033-3037. (Pubitemid 35462884)
22. Shuntaro, K., Suemarub, K., Godaa, M., Choshic, T., Hibinoc, S., Kawasakia, H., et al., 2010. Ameliorating effects of tropisetron on dopaminergic disruption of prepulse inhibition via the α7 nicotinic acetylcholine receptor in Wistar rats. Brain Res. 1353, 152-153.
23. Sieber, M., Baumgrass, R., 2009. Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506? Cell Commun. Signal. 7-25.
24. Racine, R., 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294.
25. 3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochem. Pharmacol. 70, 369-380.